Eli Lilly and Company
Headquartered in Indianapolis, Indiana, USA • Led by CEO David A. Ricks
Enterprise Market Capitalization
$790.0 Billion
-0.79% ($6.3B 24h)
Share Price: $878.00 USD
Share Price
$878.00
LLY
P/E Ratio
112.0x
Price to Earnings
Annual Revenue
$34.1B
TTM Revenue
Founded
1876
150 Years Active
Employees
43,000
Global Workforce
Exchange
NYSE
United States
Corporate Overview
Eli Lilly is an American pharmaceutical company leading breakthroughs in diabetes, obesity, immunology, and neuroscience, propelled by its blockbuster GLP-1/GIP receptor agonists Mounjaro and Zepbound.
Core Business Divisions & Flagship Offerings
Mounjaro (Tirzepatide)
Zepbound
Verzenio
Trulicity
Kisunla (Alzheimer's)
Explore All 100 Most Valued Companies
Compare market caps, sector distribution, and major shareholder networks.